China gene editing startup YolTech raises $70M to move CRISPR therapies forward on May 28, 2026 AGXT gene Amyloidosis China Clustered Regularly Interspaced Short Palindromic Repeats Gene Modification Hypercholesterolemia, Familial in vivo startup TTR wt Allele YolBE YolCas YolTech +
Patient Hospitalized After Receiving Intellia's CRISPR Therapy Dies, Prompting FDA Hold on Trials on November 07, 2025 Amyloidosis Clinical Trials Comorbidity CRISPR therapy Intellia Liver nex-z nexiguran ziclumeran patient death Phase III MAGNITUDE trial Toxicity aspects TTR wt Allele United States Food and Drug Administration +